EPAM Systems Inc (EPAM) Stock Price Today
Aura AI Summary
Key Stats
- $4.54BMARKET_CAP
- -VOLUME
- TechnologySECTOR
- $221.40FIFTY_TWO_WEEK_HIGH
- $76.04FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $3.79BENTERPRISE_VALUE
- -DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track EPAM Systems Inc (EPAM) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, EPAM Systems Inc has traded between a low of $76.04 and a high of $221.4, highlighting its annual price range. Buy and sell EPAM Systems Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About EPAM Systems Inc
EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.
Most Recent News
GrowGeneration joins U.S. Cannabis Roundtable to influence federal cannabis policy and support industry growth.
GrowGeneration Corp., a leading supplier for controlled environment agriculture, has joined the U.S. Cannabis Roundtable (USCR) to help shape federal cannabis regulations. Represented by CEO Darren Lampert, GrowGeneration aims to leverage its agricul...
Zapata Quantum CEO to present on NVIDIA collaboration and quantum cancer research at July 9 investor conference
Zapata Quantum announced that CEO Sumit Kapur will present live at the Global Technology Virtual Investor Conference on July 9, highlighting the company's collaboration with NVIDIA to accelerate quantum algorithm development and its quantum-enabled c...
Transthyretin Amyloidosis Treatment Market to hit $35.1B by 2035, growing at 14.64% CAGR driven by new RNAi therapies and diagnostics.
The global Transthyretin Amyloidosis Treatment Market, valued at $8.95 billion in 2025, is projected to reach $35.10 billion by 2035 with a CAGR of 14.64%. Growth is fueled by advances in gene-silencing RNAi therapies like patisiran and vutrisiran, i...